Trademark Overview
On Sunday, November 12, 2023, a trademark application was filed for ABILIV with the United States Patent and Trademark Office. The USPTO has given the ABILIV trademark a serial number of 98266390. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, October 16, 2024. This trademark is owned by Abbisko Therapeutics Co., Ltd.. The ABILIV trademark is filed in the Pharmaceutical Products category with the following description:
Medicines for human purposes, namely, medicinal preparations for the treatment of cancer; Capsules for medicines, namely, coated capsule medicines for prevention and treatment of human diseases, namely, anti-tumor purposes; Pharmaceutical preparations for suppressing tumors; Chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Chemical preparations for medical and pharmaceutical use for treating oncological diseases, namely, liver cancer; Pharmaceutical preparations in the form of injections for tumor suppression; Raw material drugs, namely, pharmaceuticals for anti-tumor treatment; Pharmaceutical preparations for human biomedicine, namely, cancer therapy
